Amazing developments in Russia: How the protein ‘CRYAB’ helps protect brain cells from neurodegenerative diseases.
natural defense mechanisms of the brain
Professor Vladimir Moronets, from the Institute of Physics and Biochemistry at Moscow State University, explained that this study provides scientists with unprecedented insight into the complex relationship between diabetes and Parkinson’s disease. He noted that the findings demonstrate the possibility of stimulating the brain’s “natural defense” in the early stages of the disease by modifying the properties of the CRYAB protein through targeted gene mutations, thus serving the desired therapeutic purpose. The CRYAB protein is known in the scientific community for its role as a “molecular cofactor” that protects proteins from structural breakdown when body temperature rises. It is also found in high concentrations in the lens of the eye and nerve cells. However, the Russian study focused on how the structure of this protein changes and its interaction with toxic peptides in the bodies of Parkinson’s patients who also have diabetes.
Diabetes as a “catalyst” for treatment
Researchers have hypothesized that elevated glucose levels in diabetic patients trigger a reaction between carbohydrate derivatives and the protein CRYAB, radically altering its structure and transforming it into an effective tool for breaking down harmful protein aggregates in the brain. This biochemical transformation may explain how the body can develop self-defense mechanisms under the stress of chronic diseases. The research team hopes that understanding this precise mechanism will lead to the development of a new generation of drugs that not only alleviate symptoms but also cleanse the brain of protein toxins. Experts also anticipate that this discovery will broaden the global understanding of how diabetes influences the development of a wide range of other chronic diseases, paving the way for more personalized and effective medicine.
